跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LACTEOL FORT CAPSULE - HSA Drug Approval Details
Approvals
/
HSA
/
LACTEOL FORT CAPSULE
Approved
THERAPEUTIC
LACTEOL FORT CAPSULE
ADARE PHARMACEUTICALS SAS
🇸🇬 Health Sciences Authority
Approval Date
May 27, 1998
Approval ID
40b4e63e52a0a4e2
Company
ADARE PHARMACEUTICALS SAS
Type
Therapeutic
Approval Details
Approval Id
40b4e63e52a0a4e2
Drug Name
LACTEOL FORT CAPSULE
Product Name
LACTEOL FORT CAPSULE
Approval Number
SIN09791P
Approval Date
1998-05-27
Registrant
AMSCO HEALTHCARE MARKETING PTE. LTD.
Licence Holder
AMSCO HEALTHCARE MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
CAPSULE
Dosage
Dosage and administration To be taken at the first sign of diarrhea.  The 2nd dose can be taken 6–8 hours after the 1st dose.
Route Of Administration
ORAL
Indication Info
Indications Symptomatic treatment of diarrhea.
Atc Code
A07FA01
Atc Item Name
lactic acid producing organisms
Pharma Manufacturer Name
AMSCO HEALTHCARE MARKETING PTE. LTD.
Company Detail Path
/organization/amsco-healthcare-marketing-pte-ltd
Active Ingredients
CULTURE MEDIUM (NEUTRALIZED AND LYOPHILIZED)
80 mg
LACTOBACILLUS (LYOPHILIZED MICROBIAL BODIES)
5 billion
CULTURE MEDIUM (NEUTRALIZED AND LYOPHILIZED)
80 mg
LACTOBACILLUS (LYOPHILIZED MICROBIAL BODIES)
5 billion
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 27, 1998
Approval ID
40b4e63e52a0a4e2
Type
Therapeutic
Back to HSA Approvals